Characteristics of nerve growth factor induced hyperalgesia in adult rats: Dependence on enhanced bradykinin-1 receptor activity but not neurokinin-1 receptor activation

Pain

Volumn 66, Issue 2-3, 1996, Pages 359-372

  Rueff, Alain ^a   Dawson, Andrew J L R ^a   Mendell, Lorne M ^a  

^a STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Bradykinin; Hyperalgesia; In vivo; Nerve growth factor; Neurokinin

Indexed keywords

2 BENZHYDRYL 3 (2 METHOXYBENZYLAMINO) 1 AZABICYCLO[2.2.2]OCTANE; 2 [1 IMINO 2 (2 METHOXYPHENYL)ETHYL] 7,7 DIPHENYLPERHYDROISOINDOL 4 ONE; BRADYKININ B1 RECEPTOR; NERVE GROWTH FACTOR; NEUROKININ 1 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; ETIOLOGY; FEMALE; HYPERALGESIA; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0030220204     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3959(96)03060-6     Document Type: Article

References (57)

1. Andreev N.Y., Dimitrieva N., Koltzenburg M., McMahon S.B. Peripheral administration of nerve growth factor in the adult rat produces a thermal hyperalgesia that requires the presence of sympathetic post-ganglionic neurones. Pain. 63:1995;109-115.
2. Bathon J.M., Manning D.C., Goldman D.W., Towns M.C., Proud D. Characterization of kinin receptors on human synovial cells and upregulation of receptor number by interleukin-1. J. Pharmacol. Exp. Ther. 260:1992;384-392.
3. Chapman V., Dickenson A.H. The effect of intrathecal administration of RP67580, a potent neurokinin 1 antagonist on nociceptive transmission in the rat spinal cord. Neurosci. Lett. 157:1993;149-152.
4. 1 receptors in the maintenance of intra-articular plasma extravasation in chronic antigen-induced arthritis. Br. J. Pharmacol. 113:1994;940-944.
5. 2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat. Br. J. Pharmacol. 113:1994;63-68.
6. De Biasi S., Rustioni A. Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord. Proc. Natl. Acad. Sci. USA. 85:1988;7820-7824.
7. De Koninck Y., Henry J.L. Substance P-mediated slow excitatory postsynaptic potential elicited in dorsal horn neurons in vivo by noxious stimulation. Proc. Natl. Acad. Sci. USA. 88:1991;11344-11348.
8. Della Seta D., De Acetis L., Aloe L., Alleva E. NGF effects on hot plate behaviors in mice. Pharmacol. Biochem. Behav. 49:1994;701-705.
9. Donnerer J., Schuligoi R., Stein C. Increased content and transport of substance P and calcitonin gene-related peptide in sensory nerves innervating inflamed tissue: evidence for a regulatory function of nerve growth factor in vivo. Neuroscience. 49:1992;3693-3698.
10. Dray A., Patel I.A., Perkins M.N., Rueff A. Bradykinin-induced activation of nociceptors: receptor and mechanistic studies on the neonatal rat spinal cord-tail preparation in vitro. Br. J. Pharmacol. 107:1992;1129-1134.
11. Dray A., Perkins M. Bradykinin and inflammatory pain. Trends Neurosci. 16:1993;99-104.
12. Ehrhard P.B., Ganter U., Bauer J., Otten U. Expression of functional trk protooncogene in human monocytes. Proc. Natl. Acad. Sci. USA. 90:1993;5423-5427.
13. 1 receptors in vivo during antigen arthritis. Agents Action. 34:1991;191-193.
14. Frederickson R.C.A., Burgis V., Edwards D. Hyperalgesia induced by naloxone follows diurnal rhythm in responsivity to painful stimuli. Science. 198:1977;756-758.
15. Garret C., Carruette A., Fardin V., Moussaoui S., Peyronel J.-F., Blanchard J.-C., Laduron P.M. Pharmacological properties of a potent and selective nonpeptide substance P antagonist. Proc. Natl. Acad. Sci. USA. 88:1991;10208-10212.
16. Gordon J.R., Burd P.R., Galli S.J. Mast cells as a source of multifunctional cytokines. Immunol. Today. 11:1990;458-464.
17. Hargreaves K., Dubner R., Brown F., Flores C., Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain. 32:1988;77-88.
18. Henry J.L. Participation of substance P in spinal physiological responses to peripheral aversive stimulation. Regul. Pept. 46:1993;138-143.
19. Hökfelt T., Kellerth J.O., Nilsson G., Pernow B. Substance P: localization in the central nervous system and in some primary sensory neurons. Science. 190:1975;889-890.
20. Hyman P.E., Kimura S., Tomomasa T., Yuan Q.X., Snape W.J. Jr., McRoberts J.A. Postnatal changes in the substance P receptor on rabbit gastric smooth muscle. Am. J. Physiol. 262:1992;G291-G297.
21. Kannan Y., Matsuda H., Ushio H., Kawamoto K., Shimada Y. Murine granulocyte-macrophage and mast cell colony formation promoted by nerve growth factor. Int. Arch. Allergy Immunol. 102:1993;362-367.
22. Kar S., Quirion R. Neuropeptide receptors in developing and adult rat spinal cord: an in vitro quantitative autoradiography study of calcitonin gene-related peptide, neurokinins, μ-opioid, galanin, somatostatin, neurotensin and vasoactive intestinal polypeptide receptors. J. Comp. Neurol. 354:1995;253-281.
23. Kurumaji A., Takashima M., Ohi K., Takahashi K. Circadian fluctuations in pain responsiveness and brain met-enkephalin-like immunoreactivity in the rat. Pharmacol. Biochem. Behav. 29:1988;595-599.
24. 1 receptor antagonist, on facilitation of a nociceptive spinal flexion reflex in the rat. Br. J. Pharmacol. 109:1993;713-718.
25. Levine, J. and Taiwo, Y., Inflammatory pain. In: P.D. Wall and R. Melzack (Eds.), Textbook of Pain, 3, Churchill Livingstone, Edinburgh, 1994, pp. 45-56.
26. Lewin G.R., Mendell L.M. Nerve growth factor and nociception. Trends Neurosci. 16:1993;353-359.
27. Lewin G.R., Ritter A.M., Mendell L.M. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J. Neurosci. 13:1993;2136-2148.
28. Lewin G.R., Rueff A., Mendell L.M. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur. J. Neurosci. 6:1994;1903-1912.
29. Lindholm D., Heumann R., Meyer M., Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature. 330:1987;658-659.
30. Lindsay R.M., Harmar A.J. Nerve growth factor regulates expression of neuropeptide genes in adult sensory neurons. Nature. 337:1989;362-364.
31. Manning D.C., Raja S.N., Meyer R.A., Campbell J.N. Pain and hyperalgesia after intradermal injection of bradykinin in humans. Clin. Pharmacol. Ther. 50:1991;721-729.
32. Martinez-Gomez M., Cruz Y., Salas M., Hudson R., Pacheco P. Assessing pain thresholds in the rat: changes with estrus and time of the day. Physiol. Behav. 55:1994;651-657.
33. McCarson K.E., Krause J.E. NK-1 and NK-3 type tachykinin receptor mRNA expression in the rat spinal cord dorsal horn is increased during adjuvant or formalin-induced nociception. J. Neurosci. 14:1994;712-720.
34. McNeill D.L., Westlund K.N., Coggeshall R.E. Peptide immunoreactivity of unmyelinated primary afferent axons in rat lumbar dorsal roots. J. Histochem. Cytochem. 37:1989;1047-1052.
35. McNulty J.A., Fox L.M., Silberman S. Immunocytochemical demonstration of nerve growth factor (NGF) receptor in the pineal gland: effect of NGF on pinealocyte neurite formation. Brain Res. 610:1993;108-114.
36. Nagahisa A., Asai R., Kanai Y., Murase A., Tsuchiya-Nakagaki M., Nakagaki T., Shieh T.C., Taniguchi K. Non-specific activity of (±)-CP-96345 in models of pain and inflammation. Br. J. Pharmacol. 107:1992;273-275.
37. 1 receptors in vivo in a model of ultra-violet irradiation-induced thermal hyperalgesia in the rat. Br. J. Pharmacol. 110:1993;1441-1444.
38. 8]BK and HOE140, in two models of persistent hyperalgesia in the rat. Pain. 53:1993;191-197.
39. Petty B.G., Cornblath D.R., Aldornato B.T., Chaudhry V., Flexner C., Wachsman M., Sinicropi D., Burton L.E., Peroutka S.J. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann. Neurol. 36:1994;244-246.
40. Proud D., MacGlashan D.W. Jr., Newball H.H., Schulman E.S., Lichtenstein L.M. Immunoglobulin E-mediated release of a kininogenase from purified human lung mast cells. Am. Rev. Respir. Dis. 132:1985;405-408.
41. Regoli D., Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32:1980;1-46.
42. 1 receptors, Soc. Neurosci. Abstr., 20 (1994) 287.2.
43. Rueff, A. and Mendell, L.M., NGF-induced increase in thermal sensitivity of nociceptive fibers in vitro, Soc. Neurosci. Abstr., 21 (1995) 605.16.
44. Sandrini G., Alfonsi E., Bono G., Facchinetti F., Montalbetti L., Nappi G. Circadian variations of human flexion reflex. Pain. 25:1986;403-410.
45. Schäfer M.K.-H., Nohr D., Krause J.E., Weihe E. Inflammation-induced upregulation of NK1 receptor mRNA in dorsal horn neurons. Neuro Rep. 4:1993;1007-1010.
46. 1) receptor. Science. 251:1991;435-439.
47. Steranka L.R., Manning D.C., DeHaas C.J., Ferkany J.W., Borosky S.A., Connor J.R., Vavrek R.J., Stewart J.M., Snyder S.H. Bradykinin as a pain mediator: receptors are localized to sensory neurons, and antagonists have analgesic actions. Proc. Natl. Acad. Sci. USA. 85:1988;3245-3249.
48. Stoessl A.J., Polanski E., Frydryszak H. Effects of aging on tachykinin function in the basal ganglia. Brain Res. 632:1993;21-28.
49. Taiwo Y.O., Heller P.H., Levine J.D. Characterization of distinct phospholipases mediating bradykinin and noradrenaline hyperalgesia. Neuroscience. 39:1990;523-531.
50. 2 receptor activation to high threshold afferent fibre evoked ventral root responses in the rat spinal cord in vitro. Brain Res. 625:1993;100-108.
51. 1 neurokinin receptor activation and enhanced A- and C-fiber mediated responses in the rat spinal cord in vitro. J. Neurosci. 14:1994;3672-3687.
52. Thompson S.W.N., Dray A., McCarson K.E., Krause J.E., Urban L. Nerve growth factor induces mechanical allodynia associated with novel A fiber-evoked spinal reflex activity and enhanced neurokinin-1 receptor activation in the rat. Pain. 62:1995;219-231.
53. Tuchscherer M.M., Seybold V.S. Immunohistochemical studies of substance P, cholecystokinin-octapeptide and somatostatin in dorsal root ganglia of the rat. Neuroscience. 14:1985;593-605.
54. Urban L., Thompson S.W.N., Dray A. Modulation of spinal excitability: co-operation between neurokinin and excitatory amino acid neurotransmitters. Trends Neurosci. 17:1994;432-433.
55. Wirth K., Hock F.J., Albus U., Linz W., Alpermann H.G., Anagnostopoulos H., Henke St., Breipohl G., König W., Knolle J., Schoelkens B.A. HOE 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br. J. Pharmacol. 102:1991;774-777.
56. Woolf C.J., Safieh-Garabedian B., Ma Q.-P., Crilly P., Winter J. Nerve growth factor contributes to the generation of inflammatory sensory hypersensitivity. Neuroscience. 62:1994;327-331.
57. Yashpal K., Radhakrishnan V., Coderre T.J., Henry J.L. CP-96345, but not its stereoisomer, CP-96344, blocks the nociceptive responses to intrathecally administered substance P and the noxious thermal and chemical stimuli in the rat. Neuroscience. 52:1993;1039-1047.